HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular analysis of activation-induced cytidine deaminase gene in immunoglobulin-E deficient patients.

Abstract
Understanding how class switch recombination (CSR) is regulated to produce immunoglobulin E (IgE) has become fundamental because of the dramatic increase in the prevalence of IgE-mediated hypersensitivity reactions. CSR requires the induction of the enzyme AICDA in B cells. Mutations in AICDA have been linked to Hyper-IgM syndrome (HIGM2), which shows absence of switching to IgE as well as to IgG and IgA. Although isolated IgE deficiency is a rare entity, here we show some individuals with normal serum IgM, IgG, and IgA levels that had undetectable total serum IgE levels. We have analyzed the AICDA gene in these individuals to determine if there are mutations in AICDA that could lead to selective IgE deficiency. Conformational sensitive gel electrophoresis (CSGE) and sequencing analysis of AICDA coding sequences demonstrated sequence heterogeneity due to 5923A/G and 7888C/T polymorphisms, but did not reveal any novel mutation that might explain the selective IgE deficit.
AuthorsSergio Roa, Maria Isidoro-Garcia, Ignacio Davila, Elena Laffond, Felix Lorente, Rogelio Gonzalez-Sarmiento
JournalClinical & developmental immunology (Clin Dev Immunol) Vol. 2008 Pg. 146715 ( 2008) ISSN: 1740-2530 [Electronic] Egypt
PMID19266080 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin E
  • AICDA (activation-induced cytidine deaminase)
  • Cytidine Deaminase
Topics
  • Adult
  • Base Sequence
  • Cytidine Deaminase (genetics)
  • Female
  • Humans
  • Hyper-IgM Immunodeficiency Syndrome (genetics, metabolism)
  • Immunoglobulin Class Switching (genetics)
  • Immunoglobulin E (blood, deficiency)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: